Skip to main content

Research Repository

Advanced Search

Mesenchymal stromal cells express GARP/LRRC32 on their surface: Effects on their biology and immunomodulatory capacity

Carrillo-Galvez, Ana Belén; Cobo, Marién; Cuevas-Ocaña, Sara; Gutiérrez-Guerrero, Alejandra; Sánchez-Gilabert, Almudena; Bongarzone, Pierpaolo; García-Pérez, Angélica; Muñoz, Pilar; Benabdellah, Karim; Toscano, Miguel G.; Martín, Francisco; Anderson, Per

Mesenchymal stromal cells express GARP/LRRC32 on their surface: Effects on their biology and immunomodulatory capacity Thumbnail


Authors

Ana Belén Carrillo-Galvez

Marién Cobo

Sara Cuevas-Ocaña

Alejandra Gutiérrez-Guerrero

Almudena Sánchez-Gilabert

Pierpaolo Bongarzone

Angélica García-Pérez

Pilar Muñoz

Karim Benabdellah

Miguel G. Toscano

Francisco Martín

Per Anderson



Contributors

Abstract

Mesenchymal stromal cells (MSCs) represent a promising tool for therapy in regenerative medicine, transplantation, and autoimmune disease due to their trophic and immunomodulatory activities. However, we are still far from understanding the mechanisms of action of MSCs in these processes. Transforming growth factor (TGF)-β1 is a pleiotropic cytokine involved in MSC migration, differentiation, and immunomodulation. Recently, glycoprotein A repetitions predominant (GARP) was shown to bind latency-associated peptide (LAP)/TGF-β1 to the cell surface of activated Foxp3<sup>+</sup> regulatory T cells (Tregs) and megakaryocytes/platelets. In this manuscript, we show that human and mouse MSCs express GARP which presents LAP/TGF-β1 on their cell surface. Silencing GARP expression in MSCs increased their secretion and activation of TGF-β1 and reduced their proliferative capacity in a TGF-β1-independent manner. Importantly, we showed that GARP expression on MSCs contributed to their ability to inhibit T-cell responses in vitro. In summary, we have found that GARP is an essential molecule for MSC biology, regulating their immunomodulatory and proliferative activities. We envision GARP as a new target for improving the therapeutic efficacy of MSCs and also as a novel MSC marker. Stem Cells 2015;33:183-195

Journal Article Type Article
Acceptance Date Aug 10, 2014
Online Publication Date Dec 18, 2014
Publication Date Jan 1, 2015
Deposit Date Jun 16, 2023
Publicly Available Date Jun 23, 2023
Journal Stem Cells
Print ISSN 1066-5099
Electronic ISSN 1549-4918
Publisher AlphaMed Press
Peer Reviewed Peer Reviewed
Volume 33
Issue 1
Pages 183-195
DOI https://doi.org/10.1002/stem.1821
Public URL https://nottingham-repository.worktribe.com/output/21926820
Publisher URL https://academic.oup.com/stmcls/article/33/1/183/6407053?login=false

Files





You might also like



Downloadable Citations